FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+5.77%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$38.2B
AUM Growth
-$214M
(-0.56%)
Cap. Flow
-$340M
Cap. Flow
% of AUM
-0.89%
Top 10 Holdings %
Top 10 Hldgs %
26.41%
Holding
533
New
69
Increased
170
Reduced
197
Closed
57
Top Buys
| 1 |
CMRC
Commerce.com, Inc. Series 1 Common Stock
CMRC
|
$252M |
| 2 |
Capri Holdings
CPRI
|
$216M |
| 3 |
MGM Resorts International
MGM
|
$197M |
| 4 |
SBNY
Signature Bank
SBNY
|
$186M |
| 5 |
Applied Materials
AMAT
|
$178M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$408M |
| 2 |
T-Mobile US
TMUS
|
$398M |
| 3 |
Alibaba
BABA
|
$345M |
| 4 |
Apple
AAPL
|
$344M |
| 5 |
Salesforce
CRM
|
$300M |
Sector Composition
| 1 | Technology | 34.94% |
| 2 | Healthcare | 19.8% |
| 3 | Consumer Discretionary | 14.84% |
| 4 | Financials | 9.09% |
| 5 | Communication Services | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Thermo Fisher Scientific
TMO
$186B
| $2.86M | 0.01% |
6,272
-103,270
| -94% | -$47.1M |
|
327
MarketAxess Holdings
MKTX
$7B
| $2.86M | 0.01% |
5,746
-11,734
| -67% | -$5.84M |
|
328
Biodesix
BDSX
$63.8M
| $2.83M | 0.01% |
139,106
-1,828
| -1% | -$37.1K |
|
329
Peloton Interactive
PTON
$3.27B
| $2.78M | 0.01% |
24,754
-20,063
| -45% | -$2.26M |
|
330
West Pharmaceutical
WST
$18B
| $2.75M | 0.01% |
9,765
-343
| -3% | -$96.7K |
|
|
BTRS
331
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $2.59M | 0.01% |
+178,867
| New | +$2.59M |
|
332
Blackstone
BX
$133B
| $2.58M | 0.01% |
34,544
| – | – |
|
333
Genmab
GMAB
$16.9B
| $2.57M | 0.01% |
78,338
-582,249
| -88% | -$19.1M |
|
334
Coca-Cola
KO
$293B
| $2.5M | 0.01% |
47,368
-229
| -0.5% | -$12.1K |
|
335
Chevron
CVX
$310B
| $2.46M | 0.01% |
23,512
| – | – |
|
336
Schrodinger
SDGR
$1.41B
| $2.42M | 0.01% |
31,724
+8,434
| +36% | +$643K |
|
|
SIVB
337
DELISTED
SVB Financial Group
SIVB
| $2.37M | 0.01% |
4,796
-10,019
| -68% | -$4.95M |
|
338
BioMarin Pharmaceuticals
BMRN
$11.1B
| $2.3M | 0.01% |
30,440
-415,970
| -93% | -$31.4M |
|
|
BIOR
339
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $2.29M | 0.01% |
1,926
-27
| -1% | -$32.1K |
|
340
CVS Health
CVS
$93.6B
| $2.25M | 0.01% |
29,913
+6
| +0% | +$451 |
|
341
Altria Group
MO
$112B
| $2.12M | 0.01% |
41,374
| – | – |
|
342
Merck
MRK
$212B
| $2.1M | 0.01% |
28,549
| – | – |
|
343
Strategy Inc Common Stock Class A
MSTR
$95.3B
| $2.09M | 0.01% |
30,810
-175,120
| -85% | -$11.9M |
|
344
Arrowhead Research
ARWR
$4.02B
| $2.07M | 0.01% |
31,273
-4,048
| -11% | -$268K |
|
|
TCRR
345
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $2.05M | 0.01% |
92,742
-21,616
| -19% | -$477K |
|
346
Bumble
BMBL
$696M
| $2.05M | 0.01% |
+32,818
| New | +$2.05M |
|
347
Bristol-Myers Squibb
BMY
$96B
| $2.03M | 0.01% |
32,181
-20,924
| -39% | -$1.32M |
|
348
NextEra Energy, Inc.
NEE
$146B
| $1.97M | 0.01% |
26,075
| – | – |
|
349
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$643M
| $1.9M | 0.01% |
+144,312
| New | +$1.9M |
|
|
CNST
350
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.81M | ﹤0.01% |
77,528
+31,717
| +69% | +$742K |
|